Autoantibodies against type I IFNs in patients with life
4.5
$ 1.99
In stock
(767)
Product Description
Type I interferon autoantibodies are associated with systemic
Molecular characterization of type I IFN-induced cytotoxicity in
New research may explain why some patients suffer from long-COVID
Peginterferon lambda for the treatment of outpatients with COVID
Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria
Autoantibodies against type I IFNs in patients with life
Extremely potent human monoclonal antibodies from COVID-19
The humoral response and antibodies against SARS-CoV-2 infection
Frontiers Anti-Interferon Autoantibodies in Adult-Onset
Frontiers The role of B cells in COVID-19 infection and vaccination
Autoantibody-positive healthy individuals with lower lupus risk
How cancer cells make and respond to interferon-I: Trends in Cancer
Friendly fire: How autoantibodies could drive severe Covid
Anti-interferon-γ autoantibody-associated immunodeficiency
Autoantibodies against type I IFNs in patients with life